Scientists Pave Path for Tackling Rare Cancers Without Effective Treatments
An international team of scientists led by the Icahn School of Medicine at Mount Sinai and UConn School of Medicine sequenced a genome for an extremely rare form of cancer, demonstrating the utility of this approach to open the door for therapy options for rare diseases that are neglected due to scarcity of patients or lack of resources.
Their findings were published today by JCI Insight, a journal of the American Society for Clinical Investigation.
